A detailed history of Bank Of America Corp transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 603,126 shares of TSVT stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
603,126
Previous 606,776 0.6%
Holding current value
$1.8 Million
Previous $2.34 Million 21.83%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.85 - $5.05 $14,052 - $18,432
-3,650 Reduced 0.6%
603,126 $2.85 Million
Q2 2024

Aug 14, 2024

BUY
$3.6 - $5.79 $276,166 - $444,168
76,713 Added 14.47%
606,776 $2.34 Million
Q1 2024

May 15, 2024

BUY
$3.09 - $6.0 $1.11 Million - $2.16 Million
360,019 Added 211.72%
530,063 $2.84 Million
Q4 2023

Feb 14, 2024

BUY
$1.57 - $4.58 $31,426 - $91,677
20,017 Added 13.34%
170,044 $726,000
Q2 2023

Aug 14, 2023

SELL
$8.45 - $12.48 $2.11 Million - $3.12 Million
-249,909 Reduced 62.49%
150,027 $1.52 Million
Q1 2023

May 12, 2023

BUY
$9.21 - $14.98 $2.29 Million - $3.72 Million
248,244 Added 163.65%
399,936 $4.08 Million
Q4 2022

Feb 10, 2023

BUY
$8.57 - $17.0 $246,678 - $489,328
28,784 Added 23.42%
151,692 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$12.56 - $17.54 $750,372 - $1.05 Million
59,743 Added 94.58%
122,908 $1.79 Million
Q2 2022

Aug 12, 2022

SELL
$10.55 - $18.81 $2.85 Million - $5.07 Million
-269,777 Reduced 81.03%
63,165 $833,000
Q1 2022

May 16, 2022

BUY
$11.67 - $26.72 $2.14 Million - $4.91 Million
183,690 Added 123.07%
332,942 $5.68 Million
Q4 2021

Feb 08, 2022

BUY
$13.77 - $42.56 $2.06 Million - $6.35 Million
149,252 New
149,252 $3.83 Million

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.